Seminars in oncologyHumansColchicineNeoplasmsDrug RepositioningAnti-Inflammatory Agents
Colchicine as an anti-inflammatory agent improving cancer prognosis: A therapeutic repurposing perspective.
Sigal Matza Porges, Oded Shamriz, Shlomo Z Ben-Sasson
Published: 202610.1016/j.seminoncol.2025.152437
Abstract
In this Perspective, we highlight colchicine, a centuries-old, widely available anti-inflammatory drug, as a promising therapeutic candidate in oncology. We synthesize evidence demonstrating its ability to target central pathways of cancer biology, i…
Preview only. Read the full abstract at the source